Absence of genotoxic effects of the coumarin derivative 4-methylesculetin in vivo and its potential chemoprevention against doxorubicin-induced DNA damage

Author(s)

Fedato, Rafael Palhano ^[1] ; Maistro, Edson Luis ^{[1, 2]}

Affiliation

^[1] Univ Estadual Paulista UNESP, Programa Posgrad Biol Geral & Aplicada, Inst Biociencias, Sao Paulo - Brazil

^[2] Univ Estadual Paulista UNESP, Fac Filosofia & Ciencias, Dept Fonoaudiol, BR-17525900 Marilia, SP - Brazil

• Document type: Journal article
• Source: JOURNAL OF APPLIED TOXICOLOGY; v. 34, n. 1, p. 33-39, JAN 2014.
• Web of Science Citations: 9

Abstract

4-Methylesculetin (4-ME) is a synthetic derivative of coumarin that displays a potent reactive oxygen species (ROS) scavenger and metal chelating agent and therefore has been produced to help reduce the risk of human disease. The main objective of this study was to investigate the in vivo genotoxicity of 4-ME and initially to verify its potential antigenotoxicity on doxorubicin (DXR)-induced DNA damage. Different doses of 4-ME (500, 1000 and 2000 mg kg(-1) body weight) were administered by gavage only or with a simultaneous intraperitoneal (i.p.) injection of DXR (80 mg kg(-1)). The following endpoints were analyzed: DNA damage in peripheral blood, liver, bone marrow, brain and testicle cells according to an alkaline (pH > 13) comet assay and micronucleus induction in bone marrow cells. Cytotoxicity was assessed by scoring polychromatic (PCE) and normochromatic (NCE) erythrocytes (PCE/NCE ratio). No differences were observed between the negative control and the groups treated with a 4-ME dose for any of the endpoints analyzed, indicating that it lacks genotoxic and cytotoxic effects. Moreover, 4-ME demonstrated protective effects against DXR-induced DNA damage at all tested doses and in all analyzed cell types, which ranged from 34.1% to 93.3% in the comet assay and 54.4% to 65.9% in the micronucleus test. Copyright (c) 2012 John Wiley \& Sons, Ltd. (AU)

• FAPESP's process: 10/07577-3 - Investigation of the genotoxic potential of artesunate, artemisinin, 4-hydroxicumarin and sculetin: in vitro mutagenesis methodology implantation
• Grantee: Edson Luis Maistro
• Support Opportunities: Regular Research Grants